Ketamine Therapy vs. ECT: Comparing Two Breakthrough Depression Treatments

When Depression Has Not Responded to Medication

If you have tried multiple antidepressants without meaningful relief, you are not alone — and you are not out of options. Treatment-resistant depression affects roughly one-third of people with major depressive disorder, and two of the most powerful interventions available today are ketamine therapy and electroconvulsive therapy (ECT).

Both treatments represent genuine breakthroughs. ECT has decades of clinical evidence behind it. Ketamine therapy is newer but has rapidly earned its place as a transformative option. They work through different mechanisms, involve very different experiences, and suit different situations. Understanding how they compare can help you have a more informed conversation with your provider about what makes sense for you.

What Is ECT and How Does It Work?

Electroconvulsive therapy involves passing a carefully controlled electrical current through the brain to deliberately induce a brief, generalized seizure. This may sound alarming, but modern ECT is performed under general anesthesia with a muscle relaxant, so you are fully asleep and physically still throughout the procedure. You do not feel the electrical stimulation or the seizure.

The exact mechanism behind ECT's effectiveness is still being studied, but researchers believe the induced seizures trigger widespread changes in brain chemistry and connectivity. ECT appears to increase levels of key neurotransmitters, promote neuroplasticity, and alter the function of brain circuits involved in mood regulation. It has been used since the 1930s and has been refined substantially over the decades — today's ECT bears little resemblance to the portrayals you may have seen in older media.

A typical ECT course involves two to three sessions per week for three to six weeks, totaling roughly six to twelve sessions. Each session takes about 30 minutes of procedure time, though you should plan for a few hours at the facility for preparation and recovery. ECT is performed in a hospital or specialized outpatient center.

What Is Ketamine Therapy and How Does It Work?

Ketamine works primarily by modulating the brain's glutamate system, specifically by blocking NMDA receptors in a way that triggers a cascade of neuroplastic changes. This mechanism is fundamentally different from traditional antidepressants, which target serotonin, norepinephrine, or dopamine. By promoting the rapid formation of new synaptic connections through neuroplasticity, ketamine can produce mood improvements that are faster than almost any other psychiatric treatment.

Ketamine therapy is available in several forms: intravenous (IV) infusion, intramuscular injection, sublingual tablets, and Spravato (esketamine nasal spray, the FDA-approved formulation). The most common clinical protocol involves a series of six IV infusions over two to three weeks, followed by maintenance sessions as needed.

During a ketamine session, you remain conscious but experience an altered state of awareness — often described as dreamlike, floating, or mildly dissociative. Sessions typically last 40 minutes to two hours depending on the route of administration, and you will need someone to drive you home afterward.

Effectiveness: How Do They Compare?

Both ECT and ketamine are among the most effective treatments available for depression that has not responded to standard medications. Their response rates are notably higher than simply trying another conventional antidepressant.

ECT Effectiveness

ECT is widely considered one of the most effective treatments in all of psychiatry. Response rates for treatment-resistant depression range from approximately 50 to 70 percent, with remission rates (meaning a full resolution of symptoms, not just improvement) around 30 to 50 percent. These numbers are remarkable given that the patients receiving ECT have typically already failed multiple medication trials.

ECT has the longest track record of any treatment for severe, refractory depression. It is particularly effective for depression with psychotic features, catatonia, and severe suicidal ideation.

Ketamine Effectiveness

Ketamine IV infusion has demonstrated response rates of approximately 60 to 70 percent in clinical studies of treatment-resistant depression. A single infusion can produce noticeable mood improvement in many patients, and the response tends to strengthen over the course of an initial treatment series.

Spravato (esketamine nasal spray) has shown somewhat lower but still meaningful response rates in its FDA approval studies. The real-world experience with IV ketamine in clinical settings has been encouraging, with many providers reporting substantial improvement in patients who had not responded to other treatments.

Speed of Response

This is one of the most significant differences between the two treatments. Ketamine can produce mood improvements within hours of a single session — a speed that is virtually unmatched in psychiatric treatment. This rapid onset makes ketamine uniquely valuable for patients in acute distress or experiencing suicidal ideation.

ECT, while effective, works more gradually. Most patients begin to notice improvement after several sessions, typically around the second or third week of treatment. While this is still faster than most medications, it does not approach ketamine's same-day effects.

Side Effects Comparison

ECT Side Effects

The most commonly discussed side effects of ECT involve cognition and memory:

• Memory loss is the most significant concern. Many patients experience some degree of retrograde amnesia (difficulty remembering events from before treatment) and anterograde amnesia (difficulty forming new memories during the treatment period). For most people, memory problems improve in the weeks to months after completing ECT, but some patients report persistent memory gaps.
• Confusion immediately after each session is common, typically clearing within an hour or so.
• Headache and muscle aches after treatment.
• Nausea related to general anesthesia.
• Fatigue on treatment days.
• Risks associated with general anesthesia, though serious complications are rare with modern anesthetic techniques.

Ketamine Side Effects

Ketamine's side effects are generally shorter-lived and more predictable:

• Dissociation during the session — a feeling of detachment from your body or surroundings. This fades within one to two hours after the infusion ends.
• Nausea, which can usually be managed with anti-nausea medication given before or during treatment.
• Temporary increases in blood pressure and heart rate, monitored during the session and typically resolving shortly afterward.
• Dizziness and lightheadedness during and after treatment.
• Drowsiness and fatigue for the rest of the day.
• Inability to drive for the remainder of the treatment day.

A key distinction: ketamine does not carry the memory loss concerns associated with ECT. You will not have gaps in your memory from the treatment period. The cognitive effects of ketamine are temporary and session-specific.

Cost and Insurance

ECT Costs

A single ECT session typically costs $1,000 to $2,500, and a full course of six to twelve sessions can total $6,000 to $25,000 or more depending on the facility and whether it is performed on an inpatient or outpatient basis. However, ECT is well-established and widely covered by insurance. Most major insurance plans, including Medicare, cover ECT for treatment-resistant depression. Your out-of-pocket costs will depend on your specific plan but are often manageable with insurance.

Ketamine Costs

Generic IV ketamine infusions typically cost $400 to $800 per session, with an initial series of six infusions totaling $2,400 to $4,800. Maintenance sessions add ongoing costs, commonly every two to six weeks. Insurance coverage for generic IV ketamine remains uncommon.

Spravato (esketamine nasal spray), as an FDA-approved medication, has broader insurance coverage. Copays typically range from $0 to $200 per session, though the medication's list price is high and coverage can vary.

Sublingual ketamine through telehealth providers is generally the most affordable option, with monthly costs ranging from $150 to $400, though this route involves lower bioavailability and less medical oversight.

Practical Considerations

Accessibility and Availability

ECT is available at most major hospitals and many psychiatric facilities across the country. However, it does require a facility equipped for general anesthesia, which limits it to hospital-based or specialized outpatient settings. In rural areas, accessing ECT may require travel to a larger medical center.

Ketamine therapy is available through a growing number of clinics nationwide, and the rise of telehealth providers has made at-home sublingual ketamine accessible in most states. Spravato must be administered in a certified healthcare setting under the REMS program, so availability depends on whether there is a certified provider near you.

Overall, ketamine therapy tends to be more accessible simply because it does not require the hospital infrastructure that ECT does. Telehealth options have particularly expanded access for people in underserved areas.

Who Is Each Treatment Best For?

ECT may be the better choice if:

• You have severe, life-threatening depression that requires the most proven treatment available
• Your depression includes psychotic features or catatonia
• You have responded well to ECT in the past
• Your insurance covers ECT and cost is a significant factor
• You are comfortable with general anesthesia and the possibility of temporary memory effects
• You need a treatment with the longest clinical track record

Ketamine therapy may be the better choice if:

• You need rapid relief from severe depressive symptoms or suicidal ideation
• Memory loss is a significant concern for you
• You prefer to remain conscious during treatment
• You want a treatment that does not require general anesthesia
• You have difficulty accessing a hospital-based treatment facility
• You are open to at-home treatment options (sublingual ketamine)

Can They Be Used Together?

Some patients and providers use ketamine and ECT as part of a broader treatment strategy. For example, ketamine might be used for rapid stabilization while an ECT course is being arranged, or ketamine maintenance sessions might be used after an initial ECT course to sustain improvement. There is also emerging research on using ketamine as the anesthetic agent during ECT sessions, which may enhance the combined effect.

If you are considering either or both treatments, the most important step is having a thorough conversation with a psychiatrist experienced in treatment-resistant depression. Share your treatment history, your concerns about side effects, your practical constraints, and your priorities. The right treatment is the one that aligns with your clinical needs, your values, and your life circumstances.

Both ECT and ketamine represent genuine hope for people who have struggled with depression that has not responded to conventional approaches. Neither is a magic cure, but both have helped many people find meaningful relief when nothing else had worked.

References

• NIMH: Brain Stimulation Therapies — NIMH overview of brain stimulation therapies including ECT and their effectiveness for depression
• Mayo Clinic: Electroconvulsive Therapy (ECT) — Mayo Clinic comprehensive guide to ECT, including how it works and what to expect
• NIMH: Cracking the Ketamine Code — NIMH feature on ketamine as an alternative to traditional treatments for resistant depression
• Mayo Clinic: Treatment-Resistant Depression — Mayo Clinic overview of treatment options including both ECT and ketamine-based approaches